4,4-disubstituted cyclohexylamine NK1 receptor antagonists I

被引：12
|
作者：
Elliott, JM
Castro, JL
Chicchi, GG
Cooper, LC
Dinnell, K
Hollingworth, GJ
Ridgill, MP
Rycroft, W
Kurtz, MM
Shaw, DE
Swain, CJ
Tsao, KL
Yang, LH
机构：
[1] Merck Sharp & Dohme Res Labs, Dept Med Chem, Ctr Res Neurosci, Harlow CM20 2QR, Essex, England
[2] Merck Sharp & Dohme Res Labs, Dept Pharmacol, Ctr Res Neurosci, Harlow CM20 2QR, Essex, England
[3] Merck Res Labs, Dept Biochem, Rahway, NJ 07065 USA
[4] Merck Res Labs, Dept Med Chem, Rahway, NJ 07065 USA
来源：
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2002年 / 12卷 / 13期
关键词：
D O I：
10.1016/S0960-894X(02)00249-4
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
A series of novel 4,4-disubstituted cyclohexylamine based NK1 antagonists is described. The effect of changes to the C-1-C-4 relative stereochemistry on the cyclohexane ring and replacements for the flexible linker are discussed, leading to the identification of compounds with high affinity and good in vivo duration of action. (C) 2002 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码：1755 / 1758
页数：4
相关论文
共 50 条
  • [41] Correlation of neurokinin (NK) 1 receptor occupancy in gerbil striatum with behavioral effects of NK1 antagonists
    Duffy, RA
    Varty, GB
    Morgan, CA
    Lachowicz, JE
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2002, 301 (02): : 536 - 542
  • [42] NEW APPROACH TO SYNTHESIS OF 4,4-DISUBSTITUTED CYCLOALKENONES
    BECKER, D
    KALO, J
    BRODSKY, NC
    JOURNAL OF ORGANIC CHEMISTRY, 1978, 43 (13): : 2562 - 2567
  • [43] SYNTHESIS AND PHARMACOLOGICAL EVALUATION OF 4,4-DISUBSTITUTED PIPERIDINES
    COLAPRET, JA
    DIAMANTIDIS, G
    SPENCER, HK
    SPAULDING, TC
    RUDO, FG
    JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (05) : 968 - 974
  • [44] 4,4-Disubstituted Terpyridines and Their Homoleptic FeII Complexes
    Harzmann, Gero D.
    Neuburger, Markus
    Mayor, Marcel
    EUROPEAN JOURNAL OF INORGANIC CHEMISTRY, 2013, (19) : 3334 - 3347
  • [45] Design, Synthesis, and Optimization of Balanced Dual NK1/NK3 Receptor Antagonists
    Hanessian, Stephen
    Jennequin, Thomas
    Boyer, Nicolas
    Babonneau, Vincent
    Soma, Udaykumar
    la Cour, Clotilde Mannoury
    Millan, Mark J.
    De Nanteuil, Guillaume
    ACS MEDICINAL CHEMISTRY LETTERS, 2014, 5 (05): : 550 - 555
  • [46] Combined NK1 and NK2 receptor antagonists on the bronchoconstrictor response to NKA in dogs
    Chapman, RW
    Schilling, A
    Ng, K
    Nardo, C
    Kreutner, W
    Young, S
    PULMONARY PHARMACOLOGY & THERAPEUTICS, 1999, 12 (04) : 261 - 266
  • [47] Computational studies of inclusion phenomena and synthesis of a novel and selective molecular receptor for 1,4-disubstituted benzenes and 4,4′-disubstituted biphenyls
    Macias, AT
    Kumar, KA
    Marchand, AP
    Evanseck, JD
    JOURNAL OF ORGANIC CHEMISTRY, 2000, 65 (07): : 2083 - 2089
  • [48] Molecular cloning, mutations and effects of NK1 receptor antagonists reveal the human-like pharmacology of gerbil NK1 receptors
    Engberg, Susanna
    Ahistedt, Ingela
    Leffler, Agnes
    Lindstrom, Erik
    Kristensson, Elin
    Svensson, Arne
    Pahman, Ingrid
    Johansson, Anders
    Drmota, Tomas
    von Mentzer, Bengt
    BIOCHEMICAL PHARMACOLOGY, 2007, 73 (02) : 259 - 269
  • [49] New insights into the antidepressant actions of substance P (NK1 receptor) antagonists
    Rupniak, NMJ
    CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (05) : 489 - 494
  • [50] Olanzapine and NK1 receptor antagonists for the prevention of chemotherapy induced delayed emesis
    Navari, R
    Passik, S
    Kirsh, K
    PSYCHO-ONCOLOGY, 2003, 12 (04) : S146 - S146
12345